10-Q Filing

ST JUDE MEDICAL INC CIK: 203077 Q1 2014

Filing Information

Form Type	10-Q
Accession Number	`0000203077-14-000007`
Period End Date	20140331
Filing Date	20140506
Fiscal Year	2014
Fiscal Period	Q1
XBRL Instance	stj-20140329.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 90 Income Statement 40 Cash Flow Statement 64 Comprehensive Income 16

Balance Sheet 90 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$45.00M	USD	Point-in-time
Accounts receivable allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$47.00M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.37B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.19B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.45B	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$966.00M	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $47 million and $45 million at March 29, 2014 and December 28, 2013, respectively	`AccountsReceivableNetCurrent`	$1.36B	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $47 million and $45 million at March 29, 2014 and December 28, 2013, respectively	`AccountsReceivableNetCurrent`	$1.42B	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$708.00M	USD	Point-in-time
Inventories	`InventoryNet`	$781.00M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetCurrent`	$232.00M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetCurrent`	$229.00M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$178.00M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$161.00M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$3.98B	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	289.12M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$3.91B	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	284.08M	shares	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$2.80B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	289.12M	shares	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$2.83B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	284.08M	shares	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.39B	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.43B	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.40B	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.41B	USD	Point-in-time
Goodwill	`Goodwill`	$3.52B	USD	Point-in-time
Goodwill	`Goodwill`	$3.53B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$911.00M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$890.00M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetNoncurrent`	$116.00M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetNoncurrent`	$102.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$387.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$377.00M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$10.25B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$10.29B	USD	Point-in-time
Current debt obligations	`DebtCurrent`	$62.00M	USD	Point-in-time
Current debt obligations	`DebtCurrent`	$63.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$192.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$247.00M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$77.00M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$72.00M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$32.00M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$43.00M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$312.00M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$250.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$655.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$632.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.38B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.26B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$3.52B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$3.85B	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$244.00M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$240.00M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$706.00M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$715.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.84B	USD	Point-in-time
Total liabilities	`Liabilities`	$6.06B	USD	Point-in-time
Commitments and Contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 284,075,614 and 289,117,352 shares issued and outstanding at March 29, 2014 and December 28, 2013, respectively)	`CommonStockValueOutstanding`	$29.00M	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 284,075,614 and 289,117,352 shares issued and outstanding at March 29, 2014 and December 28, 2013, respectively)	`CommonStockValueOutstanding`	$29.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$220.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$58.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.94B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.92B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$21.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$56.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$46.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$46.00M	USD	Point-in-time
Total shareholders' equity before noncontrolling interest	`StockholdersEquity`	$4.07B	USD	Point-in-time
Total shareholders' equity before noncontrolling interest	`StockholdersEquity`	$4.23B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$163.00M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$173.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.40B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.23B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$10.25B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$10.29B	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Net sales	`SalesRevenueNet`	$1.34B	USD	1 Quarter
Net sales	`SalesRevenueNet`	$1.36B	USD	1 Quarter
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$359.00M	USD	1 Quarter
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$382.00M	USD	1 Quarter
Special charges	`SpecialCharges`	$18.00M	USD	1 Quarter
Special charges	`SpecialCharges`	$1.00M	USD	1 Quarter
Total cost of sales	`CostOfGoodsSold`	$383.00M	USD	1 Quarter
Total cost of sales	`CostOfGoodsSold`	$377.00M	USD	1 Quarter
Gross profit	`GrossProfit`	$980.00M	USD	1 Quarter
Gross profit	`GrossProfit`	$961.00M	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$468.00M	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$465.00M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$160.00M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$170.00M	USD	1 Quarter
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$33.00M	USD	1 Quarter
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$25.00M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$308.00M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$312.00M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-48.00M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-20.00M	USD	1 Quarter
Earnings before noncontrolling interest and income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$260.00M	USD	1 Quarter
Earnings before noncontrolling interest and income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$292.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$53.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$38.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$239.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$222.00M	USD	1 Quarter
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-10.00M	USD	1 Quarter
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.00M	USD	1 Quarter
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$223.00M	USD	1 Quarter
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$249.00M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.88	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.78	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.78	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.86	USD	1 Quarter
Cash dividends declared per share:	`CommonStockDividendsPerShareDeclared`	$0.25	USD	1 Quarter
Cash dividends declared per share:	`CommonStockDividendsPerShareDeclared`	$0.27	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	284.40M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	285.30M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	289.30M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	287.40M	shares	1 Quarter

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net earnings before noncontrolling interest	`ProfitLoss`	$239.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$222.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$68.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$76.00M	USD	1 Quarter
Amortization of debt premium, net	`AmortizationOfDebtDiscountPremium`	$-1.00M	USD	1 Quarter
Amortization of debt premium, net	`AmortizationOfDebtDiscountPremium`	$-3.00M	USD	1 Quarter
Contingent consideration fair value adjustment, net	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$1.00M	USD	1 Quarter
Contingent consideration fair value adjustment, net	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	-	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$16.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$17.00M	USD	1 Quarter
Excess tax benefits from stock issued under employee stock plans	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	-	USD	1 Quarter
Excess tax benefits from stock issued under employee stock plans	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$9.00M	USD	1 Quarter
Deferred income taxes, net	`DeferredIncomeTaxesAndTaxCredits`	$-3.00M	USD	1 Quarter
Deferred income taxes, net	`DeferredIncomeTaxesAndTaxCredits`	$16.00M	USD	1 Quarter
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$1.00M	USD	1 Quarter
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$34.00M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-67.00M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$5.00M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$65.00M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-7.00M	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$67.00M	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$-13.00M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-96.00M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-103.00M	USD	1 Quarter
Income taxes payable	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$21.00M	USD	1 Quarter
Income taxes payable	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$10.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$183.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$273.00M	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$65.00M	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$46.00M	USD	1 Quarter
Proceeds from sale of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesEquity`	$4.00M	USD	1 Quarter
Proceeds from sale of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesEquity`	-	USD	1 Quarter
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$4.00M	USD	1 Quarter
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-42.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-69.00M	USD	1 Quarter
Proceeds from exercise of stock options and stock issued, net	`ProceedsFromStockOptionsExercised`	$60.00M	USD	1 Quarter
Proceeds from exercise of stock options and stock issued, net	`ProceedsFromStockOptionsExercised`	$51.00M	USD	1 Quarter
Excess tax benefits from stock issued under employee stock plans	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$9.00M	USD	1 Quarter
Excess tax benefits from stock issued under employee stock plans	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	-	USD	1 Quarter
Common stock repurchased, including related costs	`PaymentsForRepurchaseOfCommonStock`	$609.00M	USD	1 Quarter
Common stock repurchased, including related costs	`PaymentsForRepurchaseOfCommonStock`	$476.00M	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$68.00M	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$72.00M	USD	1 Quarter
Issuances (payments) of commercial paper borrowings, net	`ProceedsFromRepaymentsOfShortTermDebt`	$307.00M	USD	1 Quarter
Issuances (payments) of commercial paper borrowings, net	`ProceedsFromRepaymentsOfShortTermDebt`	$326.00M	USD	1 Quarter
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-14.00M	USD	1 Quarter
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-6.00M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-333.00M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-159.00M	USD	1 Quarter
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-9.00M	USD	1 Quarter
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$1.00M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$73.00M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-228.00M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.37B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.19B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.45B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$966.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.37B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.19B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.45B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$966.00M	USD	Point-in-time
Additions in noncontrolling ownership interest	`NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1`	$84.00M	USD	1 Quarter
Additions in noncontrolling ownership interest	`NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1`	-	USD	1 Quarter

Comprehensive Income 16 line items

Line Item	Tag	Value	Unit	Period
Net earnings before noncontrolling interest	`ProfitLoss`	$239.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$222.00M	USD	1 Quarter
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-1.00M	USD	1 Quarter
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	-	USD	1 Quarter
Unrealized gain on derivative financial instruments	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Unrealized gain on derivative financial instruments	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$3.00M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-27.00M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$10.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-25.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$10.00M	USD	1 Quarter
Total comprehensive income before noncontrolling interest	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$249.00M	USD	1 Quarter
Total comprehensive income before noncontrolling interest	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$197.00M	USD	1 Quarter
Total comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-1.00M	USD	1 Quarter
Total comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-10.00M	USD	1 Quarter
Total comprehensive income attributable to St. Jude Medical, Inc.	`ComprehensiveIncomeNetOfTax`	$259.00M	USD	1 Quarter
Total comprehensive income attributable to St. Jude Medical, Inc.	`ComprehensiveIncomeNetOfTax`	$198.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.